Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I REsearch on Multi-antigen T Cell Infusion Against Neuro-oncologic Disease

NCT03652545 is registered in ClinicalTrials.gov with Catherine Bollard as lead sponsor.

NCT NCT03652545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03652545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I REsearch on Multi-antigen T Cell Infusion Against Neuro-oncologic Disease
Lead sponsor
Catherine Bollard
Phase
Phase 1
Overall status
Active, not recruiting
Start date
December 12, 2018
Completion date
December 31, 2028
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor